The goal of this observational study is to learn about the long-term safety of Cellgram-LC in patients with alcoholic liver cirrhosis who previously received Cellgram-LC in the PMC-P-07 study. The main question it aims to answer is: \- Do adverse event of special interest (AESI) or liver transplantation occur during the 5 years after Cellgram-LC administration? Participants who previously received Cellgram-LC in the PMC-P-07 study and voluntarily consent to participate in this long-term follow-up study will be followed for 5 years after Cellgram-LC administration through telephone visits to collect information on AESI and liver transplantation.
Study Type
OBSERVATIONAL
Enrollment
100
Korea University Ansan Hospital
Ansan, South Korea
RECRUITINGSoonchunhyang University Hospital
Bucheon-si, South Korea
RECRUITINGSoonchunhyang University Hospital
Cheonan, South Korea
TERMINATEDGangwon National University Hospital
Chuncheon, South Korea
TERMINATEDHallym Univ. Medical Center
Chuncheon, South Korea
RECRUITINGGangneung Asan Hospital
Gangneung-si, South Korea
RECRUITINGEunpyeong St. Mary's Hospital
Seoul, South Korea
RECRUITINGGangnam Severance Hospital
Seoul, South Korea
RECRUITINGKorea University Anam Hospital
Seoul, South Korea
RECRUITINGSeoul National University Hospital
Seoul, South Korea
RECRUITING...and 4 more locations
Incidence of Adverse Event of Special Interest (AESI)
Adverse event of special interest (AESI) include death, neoplasm or malignancy in any tissue or organ, immune reactions including worsening of pre-existing autoimmune disease or new-onset autoimmune disease, and other delayed adverse events considered related to Cellgram-LC.
Time frame: From the date of Cellgram-LC administration through 5 years after administration, assessed annually.
Occurrence of Liver Transplantation
The number and percentage of participants who undergo liver transplantation will be summarized during the 5-year follow-up period after Cellgram-LC administration.
Time frame: From the date of Cellgram-LC administration through 5 years after administration, assessed annually.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.